Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
The unique ORS effervescent tablet has been developed according to the latest guidelines of the WHO. It has a substantial marketshare in several countries. We are looking for partners to further expand this success. More
These radioactive compounds have the very unique and unprecedented ability to bind very specifically and irreversibly to butyrylcholinesterase (BChE). More
Nanoparticles that exhibit high epithelial uptake and transepithelial transport More
High concentrated liquid Omega 3 for infants More
Novel micelles by creating amphiphilic block copolymers... More
MRI contast medium More
Biomimic prenatal and postnatal maternal-to-infant transfer of clinical monosaccharides for improved neurologic development and immunologic functions More
MRI contast medium More
Effective, safe, non-hormonal contraceptive for both male and female More
Related Reports
Market Research Reports provided by reports.innovaro.com
Nov 2010 - 27 pages - $99
Nov 2010 - 506 pages - $600
Apr 2010 - 17 pages - $99
Nov 2010 - 23 pages - $99
Nov 2010 - 24 pages - $99
Sep 2010 - 24 pages - $99
Sep 2010 - 27 pages - $99
Aug 2010 - 22 pages - $99
Nov 2010 - 40 pages - $500
Jun 2011 - 30 pages - $500
Your selection
Browse By
- Industry sector
- Generics
- Nutrition
- OTC/Non-Prescription
- Pediatric
- Personal Care
- Prescription
- Therapeutic target
- Ayuverdic medicine
- Chinese medicine
- Dietetic
- Homeopathy
- Iron excess
- Kanpo medicine
- Other
- Development phase
- Early Stage
- Preclinical
- Phase I
- Phase I/II
- Phase II
- Phase III
- Phase III/IV
- Preregistration
- Registered
© Copyright 1998-2012 Innovaro Europe Ltd 
All rights reserved. Terms and Conditions | Contact us